PPARγ induces cell cycle withdrawal: Inhibition of E2f/DP DNA-binding activity via down-regulation of PP2A

Genes and Development

Volumn 11, Issue 15, 1997, Pages 1987-1998

  Altiok, Soner ^a   Xu, Min ^a   Spiegelman, Bruce M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adipogenesis; Cell cycle; DP; E2F; PPAR ; Protein phosphatase 2A

Indexed keywords

CELL NUCLEUS RECEPTOR; HORMONE RECEPTOR; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CARRIER PROTEIN; CELL CYCLE PROTEIN; CELL RECEPTOR; DNA BINDING PROTEIN; LIGAND; MESSENGER RNA; PHOSPHOPROTEIN PHOSPHATASE; PIOGLITAZONE; RETINOBLASTOMA BINDING PROTEIN 1; TFDP1 PROTEIN, MOUSE; THIAZOLE DERIVATIVE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F;

ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; DNA BINDING; DOWN REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ADIPOCYTE; ANIMAL; CELL LINE; CELL STRAIN 3T3; CYTOLOGY; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALIA;

3T3 CELLS; ADIPOCYTES; ANIMALS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TRANSFORMED; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; LIGANDS; MICE; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS;

EID: 0030612740     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.15.1987     Document Type: Article

References (85)

1. Beijersbergen, R.L., R.M. Kerkhoven, L. Zhu, L. Carlee, F.M. Mathijs, and R. Bernards. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p 107 in vivo. Genes & Dev. 8: 2680-2690.
2. Brun R.P., P. Tontonoz, B.M. Forman, R. Ellis, J. Chen, R.M. Evans, and B.M. Spiegelman. 1996. Differential activation of adipogenesis by multiple PPAR isoforms. Genes & Dev. 10: 974-984.
3. Cao, L., B. Faha, M. Dembski, L.H. Tsai, E. Harlow, and N. Dyson. 1992. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355: 176-179.
4. Cao, Z., R.M. Umek, and S.L. McKnight. 1991. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes & Dev. 5: 1538-1552.
5. Chirgwin, J.M., A.E. Przybyla, R.J. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299.
6. Das, A., M. Gale, V. Carter, and M. Parsons. 1994. The protein phosphatase inhibitor okadaic acid induces defects in cytokinesis and organellar genome segregation in Trypanosoma brucei. J. Cell. Sci. 107: 3477-3483.
7. de Wet, J.R., K.V. Wood, M. DeLuca, D.R. Helinski, and S. Subramani. 1987. Firefly luciferase gene: Structure and expression in mammalian cells. Mol. Cell. Biol. 7: 725-737.
8. DeCaprio, J.A., J.W. Ludlow, J. Figge, J.Y. Shew, C.M. Huang, W.H. Lee, E. Marsilio, E. Paucha, and D.M. Livingston. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54: 275-283.
9. Dynlacht, B.D., O. Flores, J.A. Lees, and E. Harlow. 1994. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes & Dev. 8: 1772-1786.
10. Dyson, N., K. Buchkovich, P. Whyte, and E. Harlow. 1989. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58: 249-255.
11. Ewen, M.E., J.W. Ludlow, E. Marsilio, J.A. DeCaprio, R.C. Millikan, S.H. Cheng, E. Paucha, and D.M. Livingston. 1989. An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120. Cell 58: 257-267.
12. Feinberg, A.P. and B. Vogelstein. 1984. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137: 266-267.
13. Forman, B.M., P. Tontonoz, J. Chen, R.P. Brun, B.M. Spiegelman, and R.M. Evans. 1995. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83: 803-812.
14. Freytag, S.O., D.L. Paielli, and J.D. Gilbert. 1994. Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes & Dev. 8: 1654-1663.
15. Ginsberg, D., G. Vairo, T. Chittenden, Z.X. Xiao, G. Xu, K.L. Wydner, J.A. DeCaprio, J.B. Lawrence, and D.M. Livingston. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p 107. Genes & Dev. 8: 2665-2679.
16. Girling, R., J.F. Partridge, L.R. Bandara, N. Burden, N.F. Totty, J.J. Hsuan, and N.B. La Thangue. 1993. A new component of the transcription factor DRTF1/E2F. Nature 365: 468.
17. Guo, K., J. Wang, V. Andres, R.C. Smith, and K. Walsh. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15: 3823-3829.
18. Guy, C.T., W. Zhou, S. Kaufman, and M.O. Robinson. 1996. E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol. Cell. Biol. 16: 685-693.
19. Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lasser. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
20. Hanahan, D. 1988. Dissecting multistep tumorigenesis in transgenic mice. Annu. Rev. Genet. 22: 479-519.
21. -. 1989. Transgenic mice as probes into complex systems. Science 246: 1265-1275.
22. Hannon, G.J., D. Demetrick, and D. Beach. 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes & Dev. 7: 2378-2391.
23. Hara, E., S. Okomoto, S. Nakada, Y. Taya, S. Sekiya, and K. Oda. 1993. Protein phosphorylation required for the formation of E2F complex regulates N-myc transcription during differentiation of human embryonal carcinoma cells. Oncogene 8: 1023-1032.
24. Helm, K., J.A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70: 337-350.
25. Hochstrasser, M. 1995. Ubiquitin, proteosomes, and the regulation of intracellular protein degradation. Carr. Opin. Cell. Biol. 7: 215-223.
26. Hu, E., P. Tontonoz, and B.M. Spiegelman. 1995. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc. Natl. Acad. Sci. 92: 9856-9860.
27. Hu, E., J.B. Kim, P. Sarraf, and B.M. Spiegelman. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR-gamma. Science 274: 2100-2103.
28. Hunter, T. and J. Pines. 1994. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79: 573-582.
29. Ivey-Hoyle, M., R. Conroy, H.E. Huber, P.J. Goodhart, A. Oliff, and D.C. Heimbrook. 1993. Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol. Cell. Biol. 13: 7802-7812.
30. Johnson, D.G., J.K. Schwarz, W.D. Cress, and J.R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365: 349-352.
31. Johnson, D.G., W.D. Cress, L. Jakoi, and J.R. Nevins. 1994. Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. 91: 12823-12827.
32. Jooss, K., E.W. Lam, A. Bybee, R. Girling, R. Muller, and N.B. La Thangue. 1995. Proto-oncogenic properties of the DP family of proteins. Oncogene 10: 1529-1536.
33. Kaelin, W.G., Jr., W. Krek, W.R. Sellers, J.A. DeCaprio, F.A. Ajchenbaum, C.S. Fuchs, T. Chittenden, Y. Li, P.j. Farnham, M.A. Blanar et al. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351-364.
34. Kim, J.B. and B.M. Spiegelman. 1996. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes & Dev. 10: 1096-1107.
35. Kinoshita, N., H. Ohkura, and M. Yanagida. 1990. Distinct, essential roles of type 1 and 2A protein phosphatases in the control of the fission yeast cell division cycle. Cell 63: 405-415.
36. Kitagawa, M., H. Higashi, I. Suzuki-Takahashi, K. Segawa, S.K. Hanks, Y. Taya, S. Nishimura, and A. Okuyama. 1995. Phosphorylation of E2F-1 by cyclin A-cdk2. Oncogene 10: 229-236.
37. Kliewer, S.A., J.M. Lenhard, T.M. Willson, I. Patel, D.C. Morris, and J.M. Lehmann. 1995. A prostaglandin 12 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83: 813-819.
38. Kranenburg, O., R.P. de Groot, A.J. Van der Eb, and A. Zantema. 1995. Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile. Oncogene 10: 87-95.
39. Krek, W., D.M. Livingston, and S. Shirodkar. 1993. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262: 1557-1560.
40. Krek, W., M.E. Ewen, S. Shirodkar, Z. Arany, W.G. Kaelin, Jr., and D.M. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78: 161-172.
41. Krek, W., G. Xu, and D.M. Livingston. 1995. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83: 1149-1158.
42. La Thangue, N.B. 1994. DP and E2F proteins: Components of a heterodimeric transcription factor implicated in cell cycle control. Curr. Opin. Cell Biol. 6: 443-450.
43. La Thangue, N.B. and P.W. Rigby. 1987. An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells. Cell 49: 507-513.
44. Lassar, A. and A. Munsterberg. 1994. Wiring diagrams: Regulatory circuits and the control of skeletal myogenesis. Curr. Opin. Cell. Biol. 6: 432-442.
45. Lees, J.A., M. Saito, M. Vidal, M. Valentine, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13: 7813-7825.
46. Lehmann, J.M., L.B. Moore, T.A. Smith-Oliver, W.O. Wilkinson, T.M. Willson, and S.A. Kliewer. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270: 12953-12956.
47. Lin, F.T. and M.D. Lane. 1994. CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc. Natl. Acad. Sci. 91: 8757-8761.
48. Logan, T.J., K.L. Jordan, and D. Hall. 1994. Altered shape and cell cycle characteristics of fibroblasts expressing the E2F1 transcription factor. Mol. Biol. Cell 5: 667-678.
49. Ludlow, J.W., J.A. DeCaprio, C.M. Huang, W.H. Lee, E. Paucha, and D.M. Livingston. 1989. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56: 57-65.
50. Lukas, J., B.O. Petersen, K, Holm, J. Bartek, and K. Helin. 1996. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol. 16: 1047-1057.
51. Mangelsdorf, D.J. and R.M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83: 841-850.
52. Maniatis, T., E.F. Fritsch, and J. Sambrook. 1989. Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
53. Mayer-Jaekel, R.E., H. Ohkura, R. Gomes, E. Sunkel, S. Baumgartner, B.A. Hemmings, and D.M. Glover. 1993. The 55 kd regulatory subunit of Drosophila protein phosphatase 2A is required for anaphase. Cell 72: 621-633.
54. Melamed, D., N. Tiefenbrun, A. Yarden, and A. Kimichi. 1993. Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopietic cells. Mol. Cell. Biol. 13: 5255-5265.
55. Nurse, P. 1994. Ordering S phase and M phase in the cell cycle. Cell 79: 547-550.
56. Ormondroyd, E., S. de la Luna, and N.B. La Thangue. 1995. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F. Oncogene 11: 1437-1446.
57. Pear, W.S., G.P. Nolan, M.L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transtection. Proc. Natl. Acad. Sci. 90: 8392-8396.
58. Qin, X.Q., D.M. Livingston, W.G. Kaelin, Jr., and P.D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. 91: 10918-10922.
59. Ross, S.R., L. Choy, R.A. Graves, N. Fox, V. Solevjeva, S. Klaus, D. Ricquier, and B.M. Spiegelman. 1992. Hibernoma formation in transgenic mice and isolation of a brown adipocyte cell line expressing the uncoupling protein gene. Proc. Natl. Acad. Sci. 89: 7561-7565.
60. Samuelsson, L., K. Stromberg, K. Vikman, G. Bjursell, and S. Enerback. 1991. The CCAAT/enhancer binding protein and its role in adipocyte differentiation: Evidence for direct involvement in terminal adipocyte development. EMBO J. 10: 3787-3793.
61. Scheidereit, C., J.A. Cromlish, T. Gerster, K. Kawakami, C. Balmaceda, R.A. Currie, and R.G. Roeder. 1988. A human lymphoid-specific transcription factor that activates immunoglobulin genes is a homeobox protein. Nature 336: 551-557.
62. Shan, B. and W.H. Lee. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14: 8166-8173.
63. Shan, B., X. Zhu, P.L. Chen, T. Durfee, Y. Yang, D. Sharp, and W.H. Lee. 1992. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: Identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 12: 5620-5631.
64. Sherr, C.J. 1994. G1 phase progression: Cycling on cue. Cell 79: 551-555.
65. Sherr, C.J. and J.M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes & Dev. 9: 1149-1163.
66. Shirodkar, S., M. Ewen, J.A. DeCaprio, J. Morgan, D.M. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68: 157-166.
67. Singh, P., S.H. Wong, and W. Hong. 1994. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13: 3329-3338.
68. Skapek, S.X., J. Rhee, D.B. Spicer, and A.B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267: 1022-1024.
69. Tontonoz, P., J.B. Kim, R.A. Graves, and B.M. Spiegelman. 1993. ADD1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol. Cell. Biol. 13: 4753-4759.
70. Tontonoz, P., E. Hu, R.A. Graves, A.I. Budavari, and B.M. Spiegelman. 1994a. mPPARγ: Tissue-specific regulator of an adipocyte enhancer. Genes & Dev. 8: 1224-1234.
71. Tontonoz, P., E. Hu, and B.M. Spiegelman. 1994b. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipidactivated transcription factor. Cell 79: 1147-1156.
72. Umek, R.M., A.D. Friedman, and S.L. McKnight. 1991. CCAAT-enhancer binding protein: A component of a differentiation switch. Science 251: 288-292.
73. Warrel, R.P., S.R. Fankel, W.H. Miller, D.A. Scheinberg, L.M. Itri, W.N. Hittleman, R. Vyas, M. Andreef, A. Tafuri, A. Jakubowski, J. Gabrilove, M.S. Gordon, and E. Dmitrovsky. 1991. Differentiation therapy of acute promyelocytic leukemia with tretinoin. N. Engl. J. Med. 324: 1385-1393.
74. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
75. Wolf, D.A., H. Hermeking, T. Albert, T. Herzinger, P. Kind, and D. Eick. 1995. A complex between E2F and the pRb-related protein p130 is specifically targeted by the Simian virus 40 large T antigen during cell transformation. Oncogene 10: 2067-2078.
76. Wu, C.L., L.R. Zukerberg, C. Ngwu, E. Harlow, and J.A. Lees. 1995. In vivo association of E2F and DP family proteins. mol. Cell. Biol. 15: 2536-2546.
77. Wu, C.-L., M. Classon, N. Dyson, and E. Harlow. 1996. Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1. Mol. Cell. Biol. 16: 3698-3706.
78. Wu, Z., Y. Xie, N.L.R. Bucher, and S.R. Farmer. 1995. Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis. Genes & Dev. 9: 2350-2365.
79. Xu, G., D.M. Livingston, and W. Krek. 1995. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. 92: 1357-1361.
80. Xu, M., K.A. Sheppard, C.Y. Peng, A.S. Yee, and H. Piwnica-Worms. 1994. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol. 14: 8420-8431.
81. Yeh, W.C., Z. Cao, M. Classon, and S.L. McKnight. 1995. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes & Dev. 9: 168-181.
82. You, J. and R.C. Bird. 1995. Selective induction of cell cycle regulatory genes cdk1 (p34cdc2), cyclins A/B, and the tumor suppressor gene Rb in transformed cells by okadaic acid. J. Cell. Physiol. 164: 424-433.
83. Zalvide, J. and J.A. DeCaprio. 1995. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol. 15: 5800-5810.
84. Zhang, Y. and S.P. Chellappan. 1995. Cloning and characterization of human DP2, a novel dimerization partner of E2F. Oncogene 10: 2085-2093.
85. Zhu, Y., K. Alvares, Q. Huang, M.S. Rao, and J.K. Reddy. 1993. Cloning of a new member of the peroxisome proliferatoractivated receptor gene family from mouse liver. J. Biol. Chem. 268: 26817-26820.